Skip to content
Signalcrest
Back to entity feed
scienceentity · one source so far

moderna

for pharma researchers, biotech founders

Coolinghackernews
Signal score
25
Live items
1
Trajectory
⏳ Too early
needs a few more snapshots

Why this scored 25

every term, weighted
Velocity+32.9 / 40

Its fastest-moving item, measured against the pace of its own source

Acceleration+4.5 / 25

Whether that velocity is itself speeding up, as a per-hour rate

Cross-source spread+0.0 / 25

How many independent communities its own items come from

Recency+0.0 / 10

Decays to zero over 14 days, counted from when we first saw it

Saturation penalty−12.5 / 30

Subtracted once something is big and old — sized by its biggest item, aged from when we first saw it

Composite24.9

Weights are hand-tuned, not learned — we're calibrating them against realized trends as history accumulates. On an entity's first sighting there's no previous reading to compare against, so acceleration starts from a neutral prior rather than a measurement, and velocity falls back to engagement over its whole lifetime until a second reading exists. Full methodology

Signal history

7-day window (free)
2527

The evidence

The live items this entity's score aggregates — every community independently talking about it right now. This is the corroboration, shown, not claimed.

  1. 1
    47

    Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

    mRNA vaccine shows 42% reduction in death and recurrence rates. · for pharma researchers, biotech founders

    hackernewsCoolingscience57m ago
  2. 2
    16

    Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma

    Phase 3 shows Moderna's mRNA neoantigen vaccine effective against melanoma. · for biotech founders, pharma R&D

    hackernewsSteadyscience67d ago